Interplay between the tumor suppressor p53 and TGFβ signaling shapes embryonic body axes in Xenopus

Development

Volumn 130, Issue 17, 2003, Pages 3929-3939

  Takebayashi Suzuki, Kimiko ^a   Funami, Jun ^a   Tokumori, Daisuke ^a   Saito, Akira ^b   Watabe, Tetsuro ^b   Miyazono, Kohei ^b   Kanda, Akifumi ^a   Suzuki, Atsushi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Axis formation; Embryogenesis; p53; TGF ; Xenopus

Indexed keywords

ACTIVIN; ANTISENSE OLIGONUCLEOTIDE; BONE MORPHOGENETIC PROTEIN; CELL DNA; GROWTH FACTOR; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL DIFFERENTIATION; CELL FATE; CELL STIMULATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DNA DAMAGE; EMBRYO; EMBRYO AXIS; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENE FUNCTION; HOMEOBOX; KNOCKOUT GENE; MESODERM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; XENOPUS;

ANIMALS; BODY PATTERNING; ENDODERM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; MESODERM; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN P53; XENOPUS;

AMPHIBIA; ANIMALIA; REPTILIA; VERTEBRATA;

EID: 0042328242     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.00615     Document Type: Review

References (65)

1. Armstrong, J. F., Kaufman, M. H., Harrison, D. J. and Clarke, A. R. (1995). High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol. 5, 931-936.
2. Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R. and Kley, N. (1995). Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377, 646-649.
3. Chen, X., Weisberg, E., Fridmacher, V., Watanabe, M., Naco, G. and Whitman, M. (1997). Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389, 85-89.
4. Cho, K. W., Blumberg, B., Steinbeisser, H. and De Robertis, E. M. (1991). Molecular nature of Spemann's organizer: the role of the Xenopus homeobox gene goosecoid. Cell 67, 1111-1120.
5. Dale, L., Howes, G., Price, B. M. and Smith, J. C. (1992). Bone morphogenetic protein 4: a ventralizing factor in early Xenopus development. Development 115, 573-585.
6. Deb, S. P., Munoz, R. M., Brown, D. R., Subler, M. A. and Deb, S. (1994). Wild-type human p53 activates the human epidermal growth factor receptor promoter. Oncogene 9, 1341-1349.
7. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S. and Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356, 215-221.
8. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
9. Germain, S., Howell, M., Esslemont, G. M. and Hill, C. S. (2000). Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. Genes Dev. 14, 435-451.
10. Godley, L. A., Kopp, J. B., Eckhaus, M., Paglino, J. J., Owens, J. and Varmus, H. E. (1996). Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev. 10, 836-850.
11. Gurdon, J. B. and Bourillot, P.-Y. (2001). Morphogen gradient interpretation. Nature 413, 797-803.
12. Hall, P. A. and Lane, D. P. (1997). Tumor suppressors: a developing role for p53? Curr. Biol. 7, R144-R147.
13. Harland, R. and Gerhart, J. (1997). Formation and function of Spemann's organizer. Annu. Rev. Cell. Dev. Biol. 13, 611-667.
14. Hemmati-Brivanlou, A. and Thomsen, G. H. (1995). Ventral mesodermal patterning in Xenopus embryos: expression patterns and activities of BMP-2 and BMP-4. Dev. Genet. 17, 78-89.
15. Hill, C. S. (2001). TGF-β signalling pathways in early Xenopus development. Curr. Opin. Genet. Dev. 11, 533-540.
16. Hoever, M., Clement, J. H., Wedlich, D., Montenarh, M. and Knöchel, W. (1994). Overexpression of wild-type p53 interferes with normal development in Xenopus laevis embryos. Oncogene 9, 109-120.
17. Hupp, T. R., Meek, D. W., Midgley, C. A. and Lane, D. P. (1992). Regulation of the specific DNA binding function of p53. Cell 71, 875-886.
18. Hupp, T. R., Sparks, A. and Lane, D. P. (1995). Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83, 237-245.
19. Johnson, A. D. and Krieg, P. A. (1994). pXeX, a vector for efficient expression of cloned sequences in Xenopus embryos. Gene 147, 223-226.
20. Jones, C. M., Lyons, K. M., Lapan, P. M., Wright, C. V. and Hogan, B. L. (1992). DVR-4 (bone morphogenetic protein-4) as a posterior-ventralizing factor in Xenopus mesoderm induction. Development 115, 639-647.
21. Jones, S. N., Roe, A. E., Donehower, L. A. and Bradley, A. (1995). Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206-208.
22. Kiyama, T., Akasaka, K., Takata, K., Mitsunaga-Nakatsubo, K., Sakamoto, N. and Shimada, H. (1998). Structure and function of a sea urchin orthodenticle-related gene (HpOtx). Dev. Biol. 193, 139-145.
23. Labbé, E., Silvestri, C., Hoodless, P. A., Wrana, J. L. and Attisano, L. (1998). Smad2 and Smad3 positively and negatively regulate TGFβ-dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell 2, 109-120.
24. Lagna, G., Hata, A., Hemmati-Brivanlou, A. and Massagué, J. (1996). Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 383, 832-836.
25. Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
26. Lu, P., Barad, M. and Vize, P. D. (2001). Xenopus p63 expression in early ectoderm and neuroectoderm. Mech. Dev. 102, 275-278.
27. Macias-Silva, M., Hoodless, P. A., Tang, S. J., Buchwald, M. and Wrana, J. L. (1998). Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273, 25628-25636.
28. Massagué, J. and Chen, Y. G. (2000). Controlling TGF-β signaling. Genes Dev. 14, 627-644.
29. Mead, P. E., Brivanlou, I. H., Kelley, C. M. and Zon, L. I. (1996). BMP-4-responsive regulation of dorsal-ventral patterning by the homeobox protein Mix.1. Nature 382, 357-360.
30. Montes de Oca Luna, R., Wagner, D. S. and Lozano, G. (1995). Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203-206.
31. Muñoz-Sanjuán, I. and Hemmati-Brivanlou, A. (2001). Early posterior/ventral fate specification in the vertebrate embryo. Dev. Biol. 237, 1-17.
32. Nieuwkoop, P. D. and Faber, J. (1967). Normal Table of Xenopus laevis (Daudin). Amsterdam: North Holland Publishing Company.
33. Prives, C. and Hall, P. A. (1999). The p53 pathway. J. Pathol. 187, 112-126.
34. Rosa, F. M. (1989). Mix.1, a homeobox mRNA inducible by mesoderm inducers, is expressed mostly in the presumptive endodermal cells of Xenopus embryos. Cell 57, 965-974.
35. Ruiz i Altaba, A. and Melton, D. A. (1989a). Bimodal and graded expression of the Xenopus homeobox gene Xhox3 during embryonic development. Development 106, 173-183.
36. Ruiz i Altaba, A. and Melton, D. A. (1989b). Interaction between peptide growth factors and homoeobox genes in the establishment of antero-posterior polarity in frog embryos. Nature 341, 33-38.
37. Ruiz i Altaba, A., Choi, T. and Melton, D. A. (1991). Expression of the Xhox3 homeobox protein in Xenopus embryos: blocking its early function suggests the requirement of Xhox3 for normal posterior development. Dev. Growth. Differ. 33, 651-669.
38. Sah, V. P., Attardi, L. D., Mulligan, G. J., Williams, B. O., Bronson, R. T. and Jacks, T. (1995). A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet. 10, 175-180.
39. Sawano, A. and Miyawaki, A. (2000). Directed evolution of green fluorescent protein by a new versatile PCR strategy for site-directed and semi-random mutagenesis. Nucleic Acids Res. 28, e78.
40. Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A. and Brown, M. (2000). Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843-852.
41. Smith, W. C. and Harland, R. M. (1992). Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell 70, 829-840.
42. Sun, Y., Hegamyer, G., Cheng, Y.-J., Hildesheim, A., Chen, J.-Y., Chen, I.-H., Cao, Y., Yao, K.-T. and Colburn, N. H. (1992). An infrequent point mutation of the p53 gene in human nasoparyngeal carcinoma. Proc. Natl. Acad. Sci. USA 89, 6516-6520.
43. Suzuki, A., Ueno, N. and Hemmati-Brivanlou, A. (1997a). Xenopus msx1 mediates epidermal induction and neural inhibition by BMP4. Development 124, 3037-3044.
44. Suzuki, A., Kaneko, E., Ueno, N. and Hemmati-Brivanlou, A. (1997b). Regulation of epidermal induction by BMP2 and BMP7 signaling. Dev. Biol. 189, 112-122.
45. Suzuki, A. and Hemmati-Brivanlou, A. (2000). Xenopus embryonic E2F is required for the formation of ventral and posterior cell fates during early embryogenesis. Mol. Cell 5, 217-229.
46. Tada, M., O'Reilly, M. A. and Smith, J. C. (1997). Analysis of competence and of Brachyury autoinduction by use of hormone-inducible Xbra. Development 124, 2225-2234.
47. Tan, M., Wang, Y., Guan, K. and Sun, Y. (2000). PTGF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway. Proc. Natl. Acad. Sci. USA 97, 109-114.
48. Tchang, F., Gusse, M., Soussi, T. and Méchali, M. (1993). Stabilization and expression of high levels of p53 during early development in Xenopus laevis. Dev. Biol. 159, 163-172.
49. Thomsen, G., Woolf, T., Whitman, M., Sokol, S., Vaughan, J., Vale, W. and Melton, D. A. (1990). Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures. Cell 63, 485-493.
50. Velasco-Miguel, S., Buckbinder, L., Jean, P., Gelbert, L., Talbott, R., Laidlaw, J., Seizinger, B. and Kley, N. (1999). PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene 18, 127-137.
51. Vize, P. D. (1996). DNA sequences mediating the transcriptional response of the Mix.2 homeobox gene to mesoderm induction. Dev. Biol. 177, 226-231.
52. Vogelstein, B., Lane, D. and Levine, A. J. (2000). Surfing the p53 network. Nature 408, 307-310.
53. Wallingford, J. B., Seufert, D. W., Virta, V. C. and Vize, P. D. (1997). p53 activity is essential for normal development in Xenopus. Curr. Biol. 7, 747-757.
54. Wang, J., Shou, J. and Chen, X. (2000). Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53. Oncogene 19, 1843-1848.
55. Wang, L., Wu, Q., Qiu, P., Mirza, A., McGuirk, M., Kirschmeier, P., Greene, J. R., Wang, Y., Pickett, C. B. and Liu, S. (2001). Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J. Biol. Chem. 276, 43604-43610.
56. Watabe, T., Kim, S., Candia, A., Rothbacher, U., Hashimoto, C., Inoue, K. and Cho, K. W. (1995). Molecular mechanisms of Spemann's organizer formation: conserved growth factor synergy between Xenopus and mouse. Genes Dev. 9, 3038-3050.
57. Watanabe, M. and Whitman, M. (1999). FAST-1 is a key maternal effector of mesoderm inducers in the early Xenopus embryo. Development 126, 5621-5634.
58. Weinstein, D. C., Marden, J., Carnevali, F. and Hemmati-Brivanlou, A. (1998). FGF-mediated mesoderm induction involves the Src-family kinase Laloo. Nature 394, 904-908.
59. Whitman, M. (2001). Nodal signaling in early vertebrate embryos: themes and variations. Dev. Cell 1, 605-617.
60. Wilson, P. A. and Hemmati-Brivanlou, A. (1995). Induction of epidermis and inhibition of neural fate by Bmp-4. Nature 376, 331-333.
61. Yagi, K., Goto, D., Hamamoto, T., Takenoshita, S., Kato, M. and Miyazono, K. (1999). Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3. J. Biol. Chem. 274, 703-709.
62. Yamashita, H., ten Dijke, P., Huylebroeck, D., Sampath, T. K., Andries, M., Smith, J. C., Heldin, C. H. and Miyazono, K. (1995). Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J. Cell Biol. 130, 217-226.
63. Yamato, K., Hashimoto, S., Imamura, T., Uchida, H., Okahashi, N., Koseki, T., Ishisaki, A., Kizaki, M., Miyazono, K., Ikeda, Y. and Nishihara, T. (2001). Activation of the p21(CIP1/WAF1) promoter by bone morphogenetic protein-2 in mouse B lineage cells. Oncogene 20, 4383-4392.
64. Yeo, C.-Y., Chen, X. and Whitman, M. (1999). The role of FAST-1 and Smads in transcriptional regulation by activin during early Xenopus embryogenesis. J. Biol. Chem. 274, 26584-26590.
65. Zhao, R., Gish, K., Murphy, M., Yin, Y., Notterman, D., Hoffman, W. H., Tom, E., Mack, D. H. and Levine, A. J. (2000). Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 14, 981-993.